Pin Lu

1.3k total citations
29 papers, 648 citations indexed

About

Pin Lu is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Pin Lu has authored 29 papers receiving a total of 648 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 13 papers in Pathology and Forensic Medicine and 13 papers in Immunology. Recurrent topics in Pin Lu's work include Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Pin Lu is often cited by papers focused on Chronic Lymphocytic Leukemia Research (18 papers), Lymphoma Diagnosis and Treatment (13 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). Pin Lu collaborates with scholars based in United States, China and Japan. Pin Lu's co-authors include Y. Lynn Wang, Ailin Guo, Morton Coleman, Shuhua Cheng, Jiao Ma, Greg Coffey, Peter Martin, John P. Leonard, Natalie Galanina and Richard R. Furman and has published in prestigious journals such as Blood, The Journal of Immunology and Cancer Research.

In The Last Decade

Pin Lu

27 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pin Lu United States 13 456 359 205 185 158 29 648
Esther A. Beuling Netherlands 10 291 0.6× 211 0.6× 274 1.3× 255 1.4× 133 0.8× 10 696
Gianluca Schiavoni Italy 10 276 0.6× 177 0.5× 128 0.6× 184 1.0× 114 0.7× 17 440
Evgeny Arons United States 18 785 1.7× 509 1.4× 445 2.2× 312 1.7× 251 1.6× 46 1.0k
Raju Pillai United States 16 236 0.5× 305 0.8× 124 0.6× 191 1.0× 361 2.3× 70 743
Luhong Sun United States 10 146 0.3× 207 0.6× 127 0.6× 286 1.5× 213 1.3× 19 564
Chingiz Underbayev United States 10 394 0.9× 335 0.9× 230 1.1× 228 1.2× 162 1.0× 18 671
Tohru Miki Japan 12 149 0.3× 284 0.8× 334 1.6× 262 1.4× 223 1.4× 28 832
Elena Ruíz-Ballesteros Spain 8 211 0.5× 299 0.8× 96 0.5× 174 0.9× 164 1.0× 8 468
Kamlai Saiya-Cork United States 11 201 0.4× 222 0.6× 131 0.6× 191 1.0× 124 0.8× 15 480
Belinda Austen United Kingdom 13 568 1.2× 339 0.9× 261 1.3× 412 2.2× 318 2.0× 16 956

Countries citing papers authored by Pin Lu

Since Specialization
Citations

This map shows the geographic impact of Pin Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pin Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pin Lu more than expected).

Fields of papers citing papers by Pin Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pin Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pin Lu. The network helps show where Pin Lu may publish in the future.

Co-authorship network of co-authors of Pin Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Pin Lu. A scholar is included among the top collaborators of Pin Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pin Lu. Pin Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Pin, David A. Hennessy, & Hongli Feng. (2025). Price basis risk and demand for crop insurance: fostering crop sector resiliency in peripheral production regions. Agricultural Finance Review. 86(1). 48–71.
3.
Nejati, Reza, Pin Lu, Don A. Baldwin, et al.. (2023). Leukemic presentation and progressive genomic alterations of MCD/C5 diffuse large B-cell lymphoma (DLBCL). Molecular Case Studies. 9(4). a006283–a006283. 3 indexed citations
4.
Wu, Wenjun, Pin Lu, Priyal Patel, et al.. (2022). SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker. Oncogene. 42(6). 409–420. 4 indexed citations
5.
Lu, Pin, Shengchun Wang, Carrie A. Franzen, et al.. (2021). Ibrutinib and venetoclax target distinct subpopulations of CLL cells: implication for residual disease eradication. Blood Cancer Journal. 11(2). 39–39. 30 indexed citations
6.
Ming, Mei, Wenjun Wu, Bingqing Xie, et al.. (2018). XPO1 Inhibitor Selinexor Overcomes Intrinsic Ibrutinib Resistance in Mantle Cell Lymphoma via Nuclear Retention of IκB. Molecular Cancer Therapeutics. 17(12). 2564–2574. 36 indexed citations
7.
Coffey, Greg, Jiajia Feng, Anjali Pandey, et al.. (2018). Cerdulatinib Pharmacodynamics and Relationships to Tumor Response Following Oral Dosing in Patients with Relapsed/Refractory B-cell Malignancies. Clinical Cancer Research. 25(4). 1174–1184. 29 indexed citations
8.
Wang, Y. Lynn, Mei Ming, Bingqing Xie, et al.. (2017). XPO1 Inhibitor Selinexor Overcomes Ibrutinib Resistance in Mantle Cell Lymphoma Via Nuclear Retention of IκB. Blood. 130. 3837–3837. 1 indexed citations
10.
Guo, Ailin, Pin Lu, Natalie Galanina, et al.. (2015). Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib. Oncotarget. 7(4). 4598–4610. 35 indexed citations
11.
Lu, Pin, et al.. (2014). Influence of geographical distance and topographic difference on β diversity in two large-scale forest dynamics plots. Biodiversity Science. 21(5). 554–563. 3 indexed citations
12.
Ma, Jiao, Pin Lu, Ailin Guo, et al.. (2014). Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells. British Journal of Haematology. 166(6). 849–861. 74 indexed citations
13.
Ma, Jiao, Greg Coffey, Pin Lu, et al.. (2013). Dual SYK/JAK Inhibition Has a Broader Anti-Tumor Activity In Both ABC and GCB Types Of Diffuse Large B Cell Lymphoma. Blood. 122(21). 1833–1833. 1 indexed citations
14.
Furman, Richard R., Shuhua Cheng, Pin Lu, et al.. (2013). A Novel Mutation In Bruton Tyrosine Kinase Confers Acquired Resistance To Ibrutinib (PCI-32765) In CLL. Blood. 122(21). 4914–4914. 4 indexed citations
15.
Nayar, Utthara, Pin Lu, Jelena Vider, et al.. (2012). Abstract 4829: A purine scaffold Hsp90 inhibitor has antitumor activity in KSHV-associated malignancies by suppressing vFLIP. Cancer Research. 72(8_Supplement). 4829–4829. 1 indexed citations
16.
Nayar, Utthara, Pin Lu, Jelena Vider, et al.. (2010). Hsp90 is a viable therapeutic target in the treatment of KSHV-associated primary effusion lymphoma. Infectious Agents and Cancer. 5(S1). 1 indexed citations
17.
Lu, Pin. (2006). Uterine tumors resembling ovarian sex cord tumors: a clinicopathologic and immunohistochemical study. 1 indexed citations
18.
Lu, Pin, et al.. (2006). H_(2)O_(2) effect on adventitious root organogenesis of cucumber and mung bean hypocotyls. Xibei zhiwu xuebao. 26(12). 2506–2510. 1 indexed citations
19.
Jo, Seung‐Hee, Chunyan Yang, Qi Miao, et al.. (2006). Peroxisome Proliferator-Activated Receptor γ Promotes Lymphocyte Survival through Its Actions on Cellular Metabolic Activities. The Journal of Immunology. 177(6). 3737–3745. 31 indexed citations
20.
Lu, Pin. (2002). Progress of genetic diversity study and protocols for in-situ conservation on semi-wild Tibetan wheat. Zhiwu yichuan ziyuan xuebao. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026